Nukkleus Historical Income Statement
| NUKK Stock | USD 17.58 1.56 9.74% |
Historical analysis of Nukkleus income statement accounts such as Total Revenue of 6.5 M can show how well Nukkleus performed in making a profits. Evaluating Nukkleus income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Nukkleus's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Nukkleus latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nukkleus is a good buy for the upcoming year.
Nukkleus |
About Nukkleus Income Statement Analysis
Nukkleus Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Nukkleus shareholders. The income statement also shows Nukkleus investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Nukkleus Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Nukkleus. It is also known as Nukkleus overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Nukkleus operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Nukkleus is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Nukkleus' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Nukkleus current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.At this time, Nukkleus' Total Other Income Expense Net is quite stable compared to the past year.
| 2022 | 2023 | 2024 | 2025 (projected) | Total Operating Expenses | 3.2M | 15.2M | 17.5M | 18.3M | Cost Of Revenue | 16.3M | 4.9M | 5.7M | 5.4M |
Nukkleus income statement Correlations
Click cells to compare fundamentals
Nukkleus Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nukkleus income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 113.1K | 469.3K | 167.9K | 13.8K | 15.9K | 15.1K | |
| Selling General Administrative | 557.1K | 5.9M | 2.8M | 8.6M | 9.9M | 10.4M | |
| Total Revenue | 19.3M | 21.5M | 16.2M | 5.9M | 6.8M | 6.5M | |
| Gross Profit | 94.0K | (661.4K) | (64.9K) | 998.5K | 1.1M | 1.2M | |
| Other Operating Expenses | 19.3M | 20.2M | 19.5M | 20.1M | 23.1M | 15.3M | |
| Operating Income | (932.4K) | (6.8M) | (3.3M) | (14.2M) | (12.8M) | (12.1M) | |
| Ebit | (932.4K) | (6.8M) | (1.7M) | (8.0M) | (7.2M) | (6.8M) | |
| Ebitda | (463.1K) | (9.2M) | (1.5M) | (8.0M) | (7.2M) | (6.8M) | |
| Cost Of Revenue | 19.2M | 22.2M | 16.3M | 4.9M | 5.7M | 5.4M | |
| Total Operating Expenses | 1.0M | 28.3M | 3.2M | 15.2M | 17.5M | 18.3M | |
| Income Before Tax | (936.8K) | (11.8M) | (3.3M) | (8.5M) | (7.7M) | (7.3M) | |
| Net Income | (940.7K) | (11.8M) | (3.3M) | (8.5M) | (7.7M) | (7.3M) | |
| Income Tax Expense | (34.0K) | 6.0K | 3.9K | (3.3K) | (3.8K) | (4.0K) | |
| Net Income From Continuing Ops | (100.6K) | (936.8K) | (11.8M) | (8.5M) | (7.7M) | (7.3M) | |
| Total Other Income Expense Net | (4.4K) | (5.0M) | (3.0K) | 5.7M | 6.5M | 6.8M | |
| Net Income Applicable To Common Shares | (730.1K) | (100.6K) | (936.8K) | (11.8M) | (10.7M) | (10.1M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (39.44) | Revenue Per Share | Quarterly Revenue Growth (0.95) | Return On Assets | Return On Equity |
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.